Meet the Dividend King Stock That Yields Quadruple the S&P 500. Here's Why It's a Buy Now.
Having raised its dividend for 59 consecutive years, Federal Realty Investment Trust is the only REIT to attain Dividend King status.
Having raised its dividend for 59 consecutive years, Federal Realty Investment Trust is the only REIT to attain Dividend King status.
(RTTNews) - The Scotts Miracle-Gro Company (SMG), a marketer of branded consumer lawn and garden products in North America, on Thursday said it plans to acquire the Black Kow brand to expand its growing media and soil a…
Although Nvidia is best-known as the backbone of the artificial intelligence (AI) data center build-out, it's also become quite a successful investor.
(RTTNews) - U.K.'s equity benchmark FTSE 100 climbed higher on Thursday as slightly subdued oil market, a drop in bond yields and data showing an improvement in the nation's services sector activity aided sentiment.
Over the past year, artificial intelligence names have powered much of the market's advance—and a handful have posted gains exceeding 500%. That kind of run rarely feels like a starting point, yet several of these high-…
Grand Theft Auto VI: An Extended Look earned 31.1 million views on Netflix's English-language film list during the week of Aug. 24 to Aug. 30.
(RTTNews) - Today, we bring you a list of six stocks to watch in the coming days and months. Each company has potentially market-moving catalysts on the horizon, ranging from clinical data readouts and investor conferen…
(RTTNews) - Argan, Inc. (AGX) reported earnings for its second quarter that Increased, from last year
Management raised its 2026 capital expenditures outlook from a midpoint of $185 billion to a midpoint of $200 billion, and it said that number would be higher next year.
The executive disposed of 2,833 shares with an estimated value of ~$146,324 based on the August 31, 2026 transaction price.
For the second consecutive session, cocoa futures finished sharply lower on Wednesday as mounting evidence of plentiful supply outweighed lingering worries about West African crop quality.
December arabica coffee (KCZ26) closed down -11.35 (-3.67%) on Wednesday, and November ICE robusta coffee (RMX26) closed down -55 (-1.59%).
Lean hog futures are extending the bounce to Wednesday’s midday, with contracts up 22 to 50 cents. USDA’s national base hog price was reported at $90.39 on Wednesday morning, up 75 cents from the day prior. The CME Lean…
Live cattle futures are showing Wednesday 87 cent to $1.70 front month losses. Cash trade has been picked up in the north this week at $345 dressed, steady on the week, with live sales at $218. The Wednesday Fed Cattle …
For the second consecutive session on Wednesday, sugar futures finished sharply higher. New York contracts touched a 16.75-month high, while London white sugar reached its strongest level in a week. The advance reflects…
The S&P 500 Index ($SPX) (SPY) is up by +0.50% today, the Dow Jones Industrial Average ($DOWI) (DIA) is up by +0.79%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up by +0.17%. E-mini S&P futures (ESU26) are up +0.49%, and…
Bristol Myers Squibb and Pfizer have both seen solid gains in their share prices this year.
Enterprise clients will have to subscribe to a premium tier to gain access to Anthropic's AI model.
The dollar index (DXY00) fell from a 2.5-week high today and is down by -0.11%. The dollar gave up an overnight advance and turned lower today when WTI crude oil dropped from a 6-week high and moved lower, which eased i…
The S&P 500 Index ($SPX) (SPY) is up by +0.16% today, the Dow Jones Industrial Average ($DOWI) (DIA) is up by +0.42%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down by -0.20%. E-mini S&P futures (ESU26) are up +0.10%, a…
(RTTNews) - Biomerica, Inc. (BMRA), a biomedical technology company that develops diagnostic and therapeutic products, reported its financial results for the fourth quarter, reflecting a narrower net loss and revenue gr…
(RTTNews) - European stocks were subdued near a one-month low on Wednesday due to concerns over rising oil prices and bond yields.
The company expects to report multiple pivotal clinical results through the second half of 2027.
Stanley Druckenmiller closed out his Nvidia position two years ago, but said he would consider buying the stock again.